Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 272

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition

Open access
Ngo, Bryan, Kim, Eugenie, Osorio-Vasquez, Victoria, Doll, Sophia, Bustraan, Sophia, Liang, Roger J., Luengo, Alba, Davidson, Shawn M., Ali, Ahmed, Ferraro, Gino B., Fischer, Grant M., Eskandari, Roozbeh, Kang, Diane S., Ni, Jing, Plasger, Ariana, Rajasekhar, Vinagolu K., Kastenhuber, Edward R., Bacha, Sarah, Sriram, Roshan K., Stein, Benjamin D., Bakhoum, Samuel F., Snuderl, Matija, Cotzia, Paolo, Healey, John H., Mainolfi, Nello, Suri, Vipin, Friedman, Adam, Manfredi, Mark, Sabatini, David M., Jones, Drew R., Yu, Min, Zhao, Jean J., Jain, Rakesh K., Keshari, Kayvan R., Davies, Michael A., Vander Heiden, Matthew G., Hernando, Eva, Mann, Matthias, Cantley, Lewis C., Pacold, Michael E.·2020·Cancer Discovery

Published version of a preprint

Abstract

A hallmark of metastasis is the adaptation of tumor cells to new environments. Metabolic constraints imposed by the serine and glycine–limited brain environment restrict metastatic tumor growth. How brain metastases overcome these growth-prohibitive conditions is poorly understood. Here, we demonstrate that 3-phosphoglycerate dehydrogenase (PHGDH), which catalyzes the rate-limiting step of glucose-derived serine synthesis, is a major determinant of brain metastasis in multiple human cancer types and preclinical models. Enhanced serine synthesis proved important for nucleotide production and cell proliferation in highly aggressive brain metastatic cells. In vivo, genetic suppression and pharmacologic inhibition of PHGDH attenuated brain metastasis, but not extracranial tumor growth, and improved overall survival in mice. These results reveal that extracellular amino acid availability determines serine synthesis pathway dependence, and suggest that PHGDH inhibitors may be useful in the treatment of brain metastasis. Significance: Using proteomics, metabolomics, and multiple brain metastasis models, we demonstrate that the nutrient-limited environment of the brain potentiates brain metastasis susceptibility to serine synthesis inhibition. These findings underscore the importance of studying cancer metabolism in physiologically relevant contexts, and provide a rationale for using PHGDH inhibitors to treat brain metastasis. This article is highlighted in the In This Issue feature, p. 1241

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-19-1228

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 72

  1. Smith, 2017, Determinants of organotropic metastasis, Annu Rev Cancer Biol, 1, 403, 10.1146/annurev-cancerbio-041916-064715 · DOI
  2. McDonald, 2017, Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis, Nat Genet, 49, 367, 10.1038/ng.3753 · DOI · Paper page
  3. Jacob, 2015, Metastatic competence can emerge with selection of preexisting oncogenic alleles without a need of new mutations, Cancer Res, 75, 3713, 10.1158/0008-5472.CAN-15-0562 · DOI
  4. Valiente, 2018, The evolving landscape of brain metastasis, Trends Cancer, 4, 176, 10.1016/j.trecan.2018.01.003 · DOI · Paper page
  5. Kodack, 2015, Emerging strategies for treating brain metastases from breast cancer, Cancer Cell, 27, 163, 10.1016/j.ccell.2015.01.001 · DOI
  6. Achrol, 2019, Brain metastases, Nat Rev Dis Primers, 5, 5, 10.1038/s41572-018-0055-y · DOI · Paper page
  7. Ostrom, 2018, Brain metastases: epidemiology, Handb Clin Neurol, 149, 27, 10.1016/B978-0-12-811161-1.00002-5 · DOI · Paper page
  8. Chen, 2015, Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain, Cancer Res, 75, 554, 10.1158/0008-5472.CAN-14-2268 · DOI · Paper page
  9. Fischer, 2019, Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases, Cancer Discov, 9, 628, 10.1158/2159-8290.CD-18-1489 · DOI · Paper page
  10. Varešlija, 2019, Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets, J Natl Cancer Inst, 111, 388, 10.1093/jnci/djy110 · DOI
  11. Chen, 2016, Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer, Nature, 533, 493, 10.1038/nature18268 · DOI · Paper page
  12. Bos, 2009, Genes that mediate breast cancer metastasis to the brain, Nature, 459, 1005, 10.1038/nature08021 · DOI · Paper page
  13. Brastianos, 2015, Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets, Cancer Discov, 5, 1164, 10.1158/2159-8290.CD-15-0369 · DOI · Paper page
  14. Er, 2018, Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization, Nat Cell Biol, 20, 966, 10.1038/s41556-018-0138-8 · DOI · Paper page
  15. Valiente, 2014, Serpins promote cancer cell survival and vascular co-option in brain metastasis, Cell, 156, 1002, 10.1016/j.cell.2014.01.040 · DOI · Paper page
  16. Spector, 2015, A balanced view of the cerebrospinal fluid composition and functions: focus on adult humans, Exp Neurol, 273, 57, 10.1016/j.expneurol.2015.07.027 · DOI · Paper page
  17. Dolgodilina, 2016, Brain interstitial fluid glutamine homeostasis is controlled by blood-brain barrier SLC7A5/LAT1 amino acid transporter, J Cereb Blood Flow Metab, 36, 1929, 10.1177/0271678X15609331 · DOI
  18. Jones, 2006, Reference data for cerebrospinal fluid and the utility of amino acid measurement for the diagnosis of inborn errors of metabolism, Ann Clin Biochem, 43, 63, 10.1258/000456306775141759 · doi:10.1258/000456306775141759
  19. Rainesalo, 2004, Plasma and cerebrospinal fluid amino acids in epileptic patients, Neurochem Res, 29, 319, 10.1023/B:NERE.0000010461.34920.0c · DOI
  20. Maggs, 1995, Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle, J Clin Invest, 96, 370, 10.1172/JCI118043 · DOI · Paper page
  21. Muir, 2018, The nutrient environment affects therapy, Science, 360, 962, 10.1126/science.aar5986 · DOI
  22. Davidson, 2016, Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer, Cell Metab, 23, 517, 10.1016/j.cmet.2016.01.007 · DOI · Paper page
  23. Gui, 2016, Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin, Cell Metab, 24, 716, 10.1016/j.cmet.2016.09.006 · DOI · Paper page
  24. Davidson, 2017, Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors, Nat Med, 23, 235, 10.1038/nm.4256 · DOI · Paper page
  25. Sullivan, 2019, Determinants of nutrient limitation in cancer, Crit Rev Biochem Mol Biol, 282, 1
  26. Sullivan, 2017, When cancer needs what's non-essential, Nat Cell Biol, 19, 418, 10.1038/ncb3523 · DOI
  27. Alkan, 2018, Cytosolic aspartate availability determines cell survival when glutamine is limiting, Cell Metab, 28, 706, 10.1016/j.cmet.2018.07.021 · DOI · Paper page
  28. Sullivan, 2019, Increased serine synthesis provides an advantage for tumors arising in tissues where serine levels are limiting, Cell Metab, 29, 1410, 10.1016/j.cmet.2019.02.015 · DOI · Paper page
  29. Cantor, 2017, Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase, Cell, 169, 258, 10.1016/j.cell.2017.03.023 · DOI · Paper page
  30. Reid, 2018, Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism, Nat Commun, 9, 5442, 10.1038/s41467-018-07868-6 · DOI · Paper page
  31. Geiger, 2010, Proteomic changes resulting from gene copy number variations in cancer cells, PLoS Genet, 6, e1001090, 10.1371/journal.pgen.1001090 · DOI
  32. Eckert, 2019, Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts, Nature, 569, 723, 10.1038/s41586-019-1173-8 · DOI · Paper page
  33. Doll, 2019, The case for proteomics and phospho-proteomics in personalized cancer medicine, Proteomics Clin Appl, 13, e1800113, 10.1002/prca.201800113 · DOI
  34. Doll, 2018, Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient, Mol Oncol, 12, 1296, 10.1002/1878-0261.12326 · DOI
  35. Coscia, 2018, Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer, Cell, 175, 159, 10.1016/j.cell.2018.08.065 · DOI · Paper page
  36. Mattaini, 2016, The importance of serine metabolism in cancer, J Cell Biol, 214, 249, 10.1083/jcb.201604085 · DOI · Paper page
  37. Lin, 2007, Brain metastases: the HER2 paradigm, Clin Cancer Res, 13, 1648, 10.1158/1078-0432.CCR-06-2478 · DOI · Paper page
  38. Hofland, 2005, Combining etoposide and dexrazoxane synergizes with radiotherapy and improves survival in mice with central nervous system tumors, Clin Cancer Res, 11, 6722, 10.1158/1078-0432.CCR-05-0698 · DOI
  39. Rodriguez, 2019, Serine metabolism supports macrophage IL-1β production, Cell Metab, 29, 1003, 10.1016/j.cmet.2019.01.014 · DOI · Paper page
  40. Aupérin, 1999, Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group, N Engl J Med, 341, 476, 10.1056/NEJM199908123410703 · DOI · Paper page
  41. Samanta, 2016, PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis, Cancer Res, 76, 4430, 10.1158/0008-5472.CAN-16-0530 · DOI · Paper page
  42. Schild, 2018, Unique metabolic adaptations dictate distal organ-specific metastatic colonization, Cancer Cell, 33, 347, 10.1016/j.ccell.2018.02.001 · DOI · Paper page
  43. Basnet, 2019, Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization, Elife, 8, 5978, 10.7554/eLife.43627 · DOI
  44. Scalise, 2014, Transport mechanism and regulatory properties of the human amino acid transporter ASCT2 (SLC1A5), Amino Acids, 46, 2463, 10.1007/s00726-014-1808-x · DOI
  45. Ni, 2016, Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases, Nat Med, 22, 723, 10.1038/nm.4120 · DOI
  46. Shih, 2020, Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma, Nat Genet, 19, 1511
  47. Reungwetwattana, 2018, CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer, J Clin Oncol, 36, JCO2018783118, 10.1200/JCO.2018.78.3118 · DOI · Paper page
  48. Tawbi, 2018, Combined nivolumab and ipilimumab in melanoma metastatic to the brain, N Engl J Med, 379, 722, 10.1056/NEJMoa1805453 · DOI · Paper page
  49. Vazquez, 2013, Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors, Cancer Res, 73, 478, 10.1158/0008-5472.CAN-12-3709 · DOI
  50. Vazquez, 2011, Serine biosynthesis with one carbon catabolism and the glycine cleavage system represents a novel pathway for ATP generation, PLoS One, 6, e25881, 10.1371/journal.pone.0025881 · DOI
  51. Tedeschi, 2013, Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells, Cell Death Dis, 4, e877, 10.1038/cddis.2013.393 · DOI · Paper page
  52. Nikiforov, 2002, A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism, Mol Cell Biol, 22, 5793, 10.1128/MCB.22.16.5793-5800.2002 · DOI · Paper page
  53. Sun, 2015, cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions, Cell Res, 25, 429, 10.1038/cr.2015.33 · DOI · Paper page
  54. Morrish, 2009, c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry, Oncogene, 28, 2485, 10.1038/onc.2009.112 · DOI · Paper page
  55. Vandekeere, 2018, Serine synthesis via PHGDH is essential for heme production in endothelial cells, Cell Metab, 28, 573, 10.1016/j.cmet.2018.06.009 · DOI · Paper page
  56. Kurniawan, 2020, Glutathione restricts serine metabolism to preserve regulatory T cell function, Cell Metab, 31, 920, 10.1016/j.cmet.2020.03.004 · DOI · Paper page
  57. Le Douce, 2020, Impairment of glycolysis-derived l-serine production in astrocytes contributes to cognitive deficits in Alzheimer's disease, Cell Metab, 31, 503, 10.1016/j.cmet.2020.02.004 · DOI · Paper page
  58. Ma, 2017, Serine is an essential metabolite for effector T cell expansion, Cell Metab, 25, 345, 10.1016/j.cmet.2016.12.011 · DOI · Paper page
  59. Kang, 2019, PHGDH supports liver ceramide synthesis and sustains lipid homeostasis, bioRxiv, 1, 861
  60. Kelstrup, 2014, Rapid and deep proteomes by faster sequencing on a benchtop quadrupole ultra-high-field Orbitrap mass spectrometer, J Proteome Res, 13, 6187, 10.1021/pr500985w · DOI · Paper page
  61. Scheltema, 2014, The Q Exactive HF, a Benchtop mass spectrometer with a pre-filter, high-performance quadrupole and an ultra-high-field Orbitrap analyzer, Mol Cell Proteomics, 13, 3698, 10.1074/mcp.M114.043489 · DOI · Paper page
  62. Cho, 2014, isoMETLIN: a database for isotope-based metabolomics, Anal Chem, 86, 9358, 10.1021/ac5029177 · DOI
  63. Parker, 2017, LKB1 promotes metabolic flexibility in response to energy stress, Metab Eng, 43, 208, 10.1016/j.ymben.2016.12.010 · DOI
  64. Wenig, 2010, OpenChrom: a cross-platform open source software for the mass spectrometric analysis of chromatographic data, BMC Bioinformatics, 11, 405, 10.1186/1471-2105-11-405 · DOI · Paper page
  65. Fernandez, 1996, Correction of 13C mass isotopomer distributions for natural stable isotope abundance, J Mass Spectrom, 31, 255, 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3 · DOI · Paper page
  66. Kodack, 2012, Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases, Proc Natl Acad Sci U S A, 109, E3119, 10.1073/pnas.1216078109 · DOI · Paper page
  67. Yu, 2014, Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility, Science, 345, 216, 10.1126/science.1253533 · DOI · Paper page
  68. Klotz, 2020, Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers, Cancer Discov, 10, 86, 10.1158/2159-8290.CD-19-0384 · DOI
  69. Dong, 2019, Hyperpolarized MRI visualizes Warburg effects and predicts treatment response to mTOR inhibitors in patient-derived ccRCC xenograft models, Cancer Res, 79, 242, 10.1158/0008-5472.CAN-18-2231 · DOI
  70. Harris, 2009, Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells, Proc Natl Acad Sci U S A, 106, 18131, 10.1073/pnas.0909049106 · DOI · Paper page
  71. Crane, 2020, Hyperpolarized 13 C MRI data acquisition and analysis in prostate and brain at University of California, San Francisco, NMR Biomed, 100, e4280
  72. Tee, 2016, Sampling hyperpolarized molecules utilizing a 1 Tesla permanent magnetic field, Sci Rep, 6, 32846, 10.1038/srep32846 · doi:10.1038/srep32846

Cited by

See all 272

Metadata

Authors
Ngo, B., Kim, E., Osorio-Vasquez, V., Doll, S., Bustraan, S., Liang, R. J., Luengo, A., Davidson, S. M., Ali, A., Ferraro, G. B., Fischer, G. M., Eskandari, R., Kang, D. S., Ni, J., Plasger, A., Rajasekhar, V. K., Kastenhuber, E. R., Bacha, S., Sriram, R. K., Stein, B. D., Bakhoum, S. F., Snuderl, M., Cotzia, P., Healey, J. H., Mainolfi, N., Suri, V., Friedman, A., Manfredi, M., Sabatini, D. M., Jones, D. R., Yu, M., Zhao, J. J., Jain, R. K., Keshari, K. R., Davies, M. A., Vander Heiden, M. G., Hernando, E., Mann, M., Cantley, L. C., & Pacold, M. E.
Venue
Cancer Discovery
Published
2020-09-01
Volume
10
Issue
9
Pages
1352-1373
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3035766511
Cited by
272
References
22
FWCI
9.99
Type
journal article
Language
en
Open access
green
Funders
  • HHS | National Institutes of Health (F99CA234950, DP5OD026395, R03 DA034602-01A1, R01 CA129105, R01 CA103866, R37 AI047389, R01 CA126642, R01 CA085140, R01 CA115767, R01 CA098706, R01 CA208205, U01 CA224173, R35 CA197743, R21CA198028, R01CA168653, K22 CA175228-01A1, DP2 CA206653, R35CA197588, F31 CA250364, T32GM007287, R35 CA210057, P50 CA168504, R01CA237466, R01CA252037, R21CA212958)
  • National Science Foundation (T32GM007287)
  • U.S. Department of Defense (BC151244, W81XWH-10-1-0016, W81XWH-18-1-0491)
  • Burroughs Wellcome Fund
  • Howard Hughes Medical Institute
  • HHS | NIH | National Cancer Institute (P01 CA080124, K22CA212059, P30-CA008748, R37 AI047389, R01 CA121118-06A1, 2T32CA009666-21, R01CA2022027, P01CA206980, 1P50CA225450, U54 CA210184, 5P30CA016087)
  • Lustgarten Foundation
  • Pew Charitable Trusts
  • Breast Cancer Research Foundation
  • Mary Kay Foundation (017-32)
  • V Foundation for Cancer Research (V2017-004)
  • Shifrin-Myers Breast Cancer Discovery Fund
  • HHS | NIH | National Center for Advancing Translational Sciences (TL1TR000369, UL1TR000371)
  • Tow Foundation
  • UT | University of Texas MD Anderson Cancer Center
  • Starr Foundation
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • AIM at Melanoma
  • Cancer Prevention and Research Institute of Texas (RP170401, RP160183)
  • Max Planck Society for the Advancement of Science
  • EC | Horizon 2020 (686547)
  • European Commission (GA ERC-202120Syg_318987)
  • Novo Nordisk Foundation for the Clinical Proteomics group (NNF15CC0001)
  • Melanoma Research Alliance (688365)
  • American Association for Cancer Research (SU2C-AACR-IRG-09-16)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition. https://app.cochat.ai/papers/10.1158/2159-8290.cd-19-1228
The paper
Ngo, B., Kim, E., Osorio-Vasquez, V., Doll, S., Bustraan, S., Liang, R. J., Luengo, A., Davidson, S. M., Ali, A., Ferraro, G. B., Fischer, G. M., Eskandari, R., Kang, D. S., Ni, J., Plasger, A., Rajasekhar, V. K., Kastenhuber, E. R., Bacha, S., Sriram, R. K., . . . Pacold, M. E. (2020). Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-19-1228

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.